GDUFA II negotiations: CMOs to pay one third of facility fees
The Pharma & Biopharma Outsourcing Association (PBOA) has helped negotiate reduced fees for CMOs in the FDA’s proposed reauthorisation of the Generic Drug User Fee Amendment (GDUFA).
The Pharma & Biopharma Outsourcing Association (PBOA) has helped negotiate reduced fees for CMOs in the FDA’s proposed reauthorisation of the Generic Drug User Fee Amendment (GDUFA).
AbbVie has opened an oncology and women’s health API plant, part of its planned 120,000m2 small and large molecule manufacturing site in Singapore.
Charles River Laboratories has acquired Worcester, MA-based contract research organization (CRO) Agilux Laboratories, further bolstering the company’s early-stage services.
The US FDA has placed a Phase III trial for Cel-Sci’s head and neck cancer candidate on clinical hold.
MedPharm’s new US-based subsidiary, MP Pharma Services, has opened in Research Park Tringle to serve the growing global dermatology market.
QPS Holdings LLC and G-CURE BV will collaborate on cardiovascular drug development programs for pharmaceutical companies.